testo-alternativo
Dermatology and Venereology Insights: European Guidelines Update

Advancements in Dermatology: A Weekly Review

Dermatologia e Venerologia

Dermatology and Venereology Insights: European Guidelines Update

This episode reviews five major European guideline updates in dermatology and venereology, covering basal cell carcinoma, psoriatic arthritis, atopic eczema, actinic keratoses, and mucous membrane pemphigoid.

Login or Register to listen to this episode

Bibliography

1. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Authors: Wolchok JD, Chiarion-Sileni V, Rutkowski P, et al.
Journal: The New England journal of medicine
PMID: 39282897
DOI: 10.1056/NEJMoa2407417


2. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Authors: Tawbi HA, Schadendorf D, Lipson EJ, et al.
Journal: The New England journal of medicine
PMID: 34986285
DOI: 10.1056/NEJMoa2109970


3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Authors: Larkin J, Chiarion-Sileni V, Gonzalez R, et al.
Journal: The New England journal of medicine
PMID: 26027431
DOI: 10.1056/NEJMoa1504030


4. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Authors: Patel SP, Othus M, Chen Y, et al.
Journal: The New England journal of medicine
PMID: 36856617
DOI: 10.1056/NEJMoa2211437


5. Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer.
Authors: Hyeraci M, Papanikolau ES, Grimaldi M, et al.
Journal: Biomolecules
PMID: 37509103
DOI: 10.3390/biom13071067

Comments

Please Login to leave a comment.

No comments yet.